Literature DB >> 22180081

A divide-and-conquer approach to determine the Pareto frontier for optimization of protein engineering experiments.

Lu He1, Alan M Friedman, Chris Bailey-Kellogg.   

Abstract

In developing improved protein variants by site-directed mutagenesis or recombination, there are often competing objectives that must be considered in designing an experiment (selecting mutations or breakpoints): stability versus novelty, affinity versus specificity, activity versus immunogenicity, and so forth. Pareto optimal experimental designs make the best trade-offs between competing objectives. Such designs are not "dominated"; that is, no other design is better than a Pareto optimal design for one objective without being worse for another objective. Our goal is to produce all the Pareto optimal designs (the Pareto frontier), to characterize the trade-offs and suggest designs most worth considering, but to avoid explicitly considering the large number of dominated designs. To do so, we develop a divide-and-conquer algorithm, Protein Engineering Pareto FRontier (PEPFR), that hierarchically subdivides the objective space, using appropriate dynamic programming or integer programming methods to optimize designs in different regions. This divide-and-conquer approach is efficient in that the number of divisions (and thus calls to the optimizer) is directly proportional to the number of Pareto optimal designs. We demonstrate PEPFR with three protein engineering case studies: site-directed recombination for stability and diversity via dynamic programming, site-directed mutagenesis of interacting proteins for affinity and specificity via integer programming, and site-directed mutagenesis of a therapeutic protein for activity and immunogenicity via integer programming. We show that PEPFR is able to effectively produce all the Pareto optimal designs, discovering many more designs than previous methods. The characterization of the Pareto frontier provides additional insights into the local stability of design choices as well as global trends leading to trade-offs between competing criteria.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180081      PMCID: PMC4939273          DOI: 10.1002/prot.23237

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  63 in total

1.  Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations.

Authors:  Raphael Guerois; Jens Erik Nielsen; Luis Serrano
Journal:  J Mol Biol       Date:  2002-07-05       Impact factor: 5.469

2.  Functional evolution and structural conservation in chimeric cytochromes p450: calibrating a structure-guided approach.

Authors:  Christopher R Otey; Jonathan J Silberg; Christopher A Voigt; Jeffrey B Endelman; Geethani Bandara; Frances H Arnold
Journal:  Chem Biol       Date:  2004-03

3.  Diversification of catalytic function in a synthetic family of chimeric cytochrome p450s.

Authors:  Marco Landwehr; Martina Carbone; Christopher R Otey; Yougen Li; Frances H Arnold
Journal:  Chem Biol       Date:  2007-03

4.  Algorithms for selecting breakpoint locations to optimize diversity in protein engineering by site-directed protein recombination.

Authors:  Wei Zheng; Xiaoduan Ye; Alan M Friedman; Chris Bailey-Kellogg
Journal:  Comput Syst Bioinformatics Conf       Date:  2007

5.  A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments.

Authors:  Yougen Li; D Allan Drummond; Andrew M Sawayama; Christopher D Snow; Jesse D Bloom; Frances H Arnold
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

6.  Optimization of therapeutic proteins to delete T-cell epitopes while maintaining beneficial residue interactions.

Authors:  Andrew S Parker; Karl E Griswold; Chris Bailey-Kellogg
Journal:  J Bioinform Comput Biol       Date:  2011-04       Impact factor: 1.122

7.  De novo protein design: fully automated sequence selection.

Authors:  B I Dahiyat; S L Mayo
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

Review 8.  Humanized antibodies.

Authors:  G Winter; W J Harris
Journal:  Trends Pharmacol Sci       Date:  1993-05       Impact factor: 14.819

9.  Rationally engineered therapeutic proteins with reduced immunogenicity.

Authors:  Shabnam Tangri; Bianca R Mothé; Julie Eisenbraun; John Sidney; Scott Southwood; Kristen Briggs; John Zinckgraf; Pamuk Bilsel; Mark Newman; Robert Chesnut; Cynthia Licalsi; Alessandro Sette
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

10.  Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.

Authors:  Morten Nielsen; Claus Lundegaard; Ole Lund
Journal:  BMC Bioinformatics       Date:  2007-07-04       Impact factor: 3.169

View more
  20 in total

1.  Antibody humanization by structure-based computational protein design.

Authors:  Yoonjoo Choi; Casey Hua; Charles L Sentman; Margaret E Ackerman; Chris Bailey-Kellogg
Journal:  MAbs       Date:  2015-08-07       Impact factor: 5.857

2.  Depletion of T cell epitopes in lysostaphin mitigates anti-drug antibody response and enhances antibacterial efficacy in vivo.

Authors:  Hongliang Zhao; Deeptak Verma; Wen Li; Yoonjoo Choi; Christian Ndong; Steven N Fiering; Chris Bailey-Kellogg; Karl E Griswold
Journal:  Chem Biol       Date:  2015-05-21

3.  Structure-based design of combinatorial mutagenesis libraries.

Authors:  Deeptak Verma; Gevorg Grigoryan; Chris Bailey-Kellogg
Journal:  Protein Sci       Date:  2015-03-02       Impact factor: 6.725

Review 4.  Searching for the Pareto frontier in multi-objective protein design.

Authors:  Vikas Nanda; Sandeep V Belure; Ofer M Shir
Journal:  Biophys Rev       Date:  2017-08-10

5.  Computationally optimized deimmunization libraries yield highly mutated enzymes with low immunogenicity and enhanced activity.

Authors:  Regina S Salvat; Deeptak Verma; Andrew S Parker; Jack R Kirsch; Seth A Brooks; Chris Bailey-Kellogg; Karl E Griswold
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

6.  Pareto Optimization of Combinatorial Mutagenesis Libraries.

Authors:  Deeptak Verma; Gevorg Grigoryan; Chris Bailey-Kellogg
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2018-07-23       Impact factor: 3.710

7.  Structure-guided deimmunization of therapeutic proteins.

Authors:  Andrew S Parker; Yoonjoo Choi; Karl E Griswold; Chris Bailey-Kellogg
Journal:  J Comput Biol       Date:  2013-02       Impact factor: 1.479

8.  Computationally driven antibody engineering enables simultaneous humanization and thermostabilization.

Authors:  Yoonjoo Choi; Christian Ndong; Karl E Griswold; Chris Bailey-Kellogg
Journal:  Protein Eng Des Sel       Date:  2016-06-21       Impact factor: 1.650

Review 9.  Design and engineering of deimmunized biotherapeutics.

Authors:  Karl E Griswold; Chris Bailey-Kellogg
Journal:  Curr Opin Struct Biol       Date:  2016-06-17       Impact factor: 6.809

10.  Structure-based redesign of proteins for minimal T-cell epitope content.

Authors:  Yoonjoo Choi; Karl E Griswold; Chris Bailey-Kellogg
Journal:  J Comput Chem       Date:  2013-01-08       Impact factor: 3.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.